Yuping Han1, Shaozhen Zhao2. 1. Department of Corneal and Refractive Disease, Tianjin Medical University Eye Hospital Tianjin 300384, P. R. China ; Department of Corneal Disease, Shanxi Eye Hospital Taiyuan 030002, Shanxi, P. R. China. 2. Department of Corneal and Refractive Disease, Tianjin Medical University Eye Hospital Tianjin 300384, P. R. China.
Abstract
OBJECTIVE: It is widely reported that CD11b(+)Gr1+ myeloid-derived suppressor cells can cause allograft tolerance in mice and human, however, little is known on the therapy role in chronic transplantation rejection. In this paper, their role in corneal transplantation was studied for the first time. METHOD: Inhibitory CD11b(+) cells were obtained by murine LPS-induced septic model. Phenotype, endocytosis, antigen presenting ability, and T cell suppression assays were performed by flow cytometry analysis. The suppressive ability in vivo was analyzed by targeting allogeneic corneal transplantation. RESULTS: LPS was intraperitoneally injected into C57BL/6 mice, the percentage of CD11b(+) Gr1+ cells was increased in mice spleen, blood, and bone marrow, respectively. Compared with control mice, Ly6C, TLR2, and MHC-11 expression were higher in LPS treated mice. CD11b(+) Gr1+ cells could inhibit allogenic corneal reaction in vivo after adoptive transfer, in consistent with an observation of inhibition effect on the antigen presenting cells (APCs) and CD4+ T cells proliferation in vitro. CONCLUSION: CD11b(+) cells induced by LPS could function as inhibitory APCs, suppress CD4+ T cells proliferation and improve corneal allograft survival. Predictly, its application for cells transfer therapy in clinic in the further.
OBJECTIVE: It is widely reported that CD11b(+)Gr1+ myeloid-derived suppressor cells can cause allograft tolerance in mice and human, however, little is known on the therapy role in chronic transplantation rejection. In this paper, their role in corneal transplantation was studied for the first time. METHOD: Inhibitory CD11b(+) cells were obtained by murineLPS-induced septic model. Phenotype, endocytosis, antigen presenting ability, and T cell suppression assays were performed by flow cytometry analysis. The suppressive ability in vivo was analyzed by targeting allogeneic corneal transplantation. RESULTS:LPS was intraperitoneally injected into C57BL/6 mice, the percentage of CD11b(+) Gr1+ cells was increased in mice spleen, blood, and bone marrow, respectively. Compared with control mice, Ly6C, TLR2, and MHC-11 expression were higher in LPS treated mice. CD11b(+) Gr1+ cells could inhibit allogenic corneal reaction in vivo after adoptive transfer, in consistent with an observation of inhibition effect on the antigen presenting cells (APCs) and CD4+ T cells proliferation in vitro. CONCLUSION:CD11b(+) cells induced by LPS could function as inhibitory APCs, suppress CD4+ T cells proliferation and improve corneal allograft survival. Predictly, its application for cells transfer therapy in clinic in the further.
Authors: Khrishen Cunnusamy; Kathryn Paunicka; Nancy Reyes; Wanhua Yang; Peter W Chen; Jerry Y Niederkorn Journal: Invest Ophthalmol Vis Sci Date: 2010-08-11 Impact factor: 4.799
Authors: Jerry Y Niederkorn; Peter W Chen; Jessamee Mellon; Christina Stevens; Elizabeth Mayhew Journal: J Immunol Date: 2010-04-21 Impact factor: 5.422
Authors: Güllü Topal Görgün; Gregory Whitehill; Jennifer L Anderson; Teru Hideshima; Craig Maguire; Jacob Laubach; Noopur Raje; Nikhil C Munshi; Paul G Richardson; Kenneth C Anderson Journal: Blood Date: 2013-01-15 Impact factor: 22.113
Authors: Lydia A Haile; Reinhard von Wasielewski; Jaba Gamrekelashvili; Christine Krüger; Oliver Bachmann; Astrid M Westendorf; Jan Buer; Roland Liblau; Michael P Manns; Firouzeh Korangy; Tim F Greten Journal: Gastroenterology Date: 2008-06-12 Impact factor: 22.682
Authors: V De Wilde; N Van Rompaey; M Hill; J F Lebrun; P Lemaître; F Lhommé; C Kubjak; B Vokaer; G Oldenhove; L M Charbonnier; M C Cuturi; M Goldman; A Le Moine Journal: Am J Transplant Date: 2009-07-22 Impact factor: 8.086